"Elon Musk's Ketamine Use Raises Concerns at Tesla and SpaceX"
Professionals, including executives and working women, are increasingly using substances like LSD, psilocybin, and ketamine as mechanisms to improve their work performance. The psychedelics market is expected to reach $11 billion by 2027. While microdosing is popular among some, the scientific evidence on its effectiveness is still inconclusive. Some corporate elites are attending luxury psychedelic retreats to improve their leadership skills, but the use of psychedelics in the workplace raises concerns about safety, legal risks, and social pressures. Despite the potential risks and benefits, the trend of using drugs as a work-enhancement tool seems to be gaining traction in the corporate world.
